Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | ADORA2B | P29275 | 6/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | PDE4A | P27815 | 1/20 | 0.40 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.40 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3848063 | 0.85 | ADORA2B (0.60) | POLBADORA2BADORA2AMEN1KMT2A | |
| SCHEMBL10432472 | 0.83 | ALDH1A1 (0.60) | POLBCYP2C19CYP3A4ADORA2BADORA2A | |
| SCHEMBL8571170 | 0.82 | CYP3A4 (0.49) | POLBCYP2C19CYP3A4ADORA2BADORA2A | |
| SCHEMBL59950 | 0.77 | ADORA2B (0.48) | POLBCYP2C19CYP3A4ADORA2BADORA2A | |
| SCHEMBL9406540 | 0.76 | POLB (0.83) | POLBCYP2C19CYP3A4ALDH1A1CYP1A2 | |
| SCHEMBL2958489 | 0.76 | ADORA2B (0.58) | POLBCYP2C19ADORA2BADORA2AKDM4E | |
| SCHEMBL9414260 | 0.76 | PARP1 (0.43) | POLBCYP2C19CYP3A4KDM4EMEN1 | |
| SCHEMBL9845191 | 0.74 | XDH (0.40) | POLBCYP2C19CYP3A4ALDH1A1MAPK1 | |
| SCHEMBL21935452 | 0.74 | ADORA2B (0.54) | CYP3A4ADORA2BADORA2AKDM4EMEN1 | |
| SCHEMBL6233162 | 0.73 | XDH (0.51) | ADORA2BALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2875126-B1 | ERYTHROID PRODUCTION | THE COMMON SERVICES AGENCY (GB) | 2018-01-17 | — | — | EP | claimed |
| US-20150203818-A1 | ERYTHROID PRODUCTION | UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW (GB) | 2015-07-23 | — | — | US | claimed |
| EP-2875126-A1 | ERYTHROID PRODUCTION | The Common Services Agency (GB) | 2015-05-27 | — | — | EP | claimed |
| WO-2014013255-A1 | ERYTHROID PRODUCTION | THE COMMON SERVICES AGENCY (GB) | 2014-01-23 | — | — | WO | claimed |
| WO-2009131948-A2 | HIGH-THROUGHPUT CELL-BASED CFTR ASSAY | INSTITUTE FOR ONEWORLD HEALTH (US) | 2009-10-29 | — | — | WO | claimed |
| EP-0956855-B1 | Immunosuppressive effects of 8 substituted xanthine derivatives | LEUVEN K U RES & DEV (BE) | 2003-03-12 | — | — | EP | claimed |
| EP-0956855-A1 | Immunosuppressive effects of 8-substituted xanthine derivatives | K.U. Leuven Research & Development (BE) | 1999-11-17 | — | — | EP | claimed |
| US-20250283041-A1 | METHODS FOR PRODUCING RED BLOOD CELLS | ALBERT EINSTEIN COLLEGE MEDICINE (US) | 2025-09-11 | — | — | US | disclosed |
| EP-4532693-A1 | METHODS FOR PRODUCING RED BLOOD CELLS | Albert Einstein College of Medicine (US) | 2025-04-09 | — | — | EP | disclosed |
| EP-4401833-A1 | GPR52 MODULATOR COMPOUNDS | Nxera Pharma UK Limited (GB) | 2024-07-24 | — | — | EP | disclosed |
| WO-2023230405-A1 | METHODS FOR PRODUCING RED BLOOD CELLS | ALBERT EINSTEIN COLLEGE OF MEDICINE (US) | 2023-11-30 | — | — | WO | disclosed |
| EP-4204408-A1 | GPR52 MODULATOR COMPOUNDS | Heptares Therapeutics Limited (GB) | 2023-07-05 | — | — | EP | disclosed |
| WO-2023041909-A1 | GPR52 MODULATOR COMPOUNDS | HEPTARES THERAPEUTICS LIMITED (GB) | 2023-03-23 | — | — | WO | disclosed |
| WO-2005118779-A1 | METHOD FOR PRODUCING PLURIPOTENT CELLS FROM MONOCYTES | UNIV GOETTINGEN GEORG AUGUST (DE) | 2005-12-15 | — | — | WO | disclosed |
| US-5470579-A | Xanthines, optionally incorporated in liposomes, for promoting skin or hair pigmentation | LVMH, RECHERCHE (FR) | 1995-11-28 | — | — | US | disclosed |
| EP-0535038-A4 | MAMMALIAN ADIPOGENIC FACTORS | — | 1993-12-29 | — | — | EP | disclosed |
| EP-0535038-A1 | MAMMALIAN ADIPOGENIC FACTORS | W. ALTON JONES CELL SCIENCE CENTER (US) | 1993-04-07 | — | — | EP | disclosed |
| WO-1991018924-A1 | MAMMALIAN ADIPOGENIC FACTORS | W. ALTON JONES CELL SCIENCE CENTER (US) | 1991-12-12 | — | — | WO | disclosed |
| EP-0308460-A1 | A COMPOSITION FOR THE TOPICAL TREATMENT OF GLAUCOMA OR OCULAR HYPERTENSION. | PHARMACIA AB (SE) | 1989-03-29 | — | — | EP | disclosed |
| WO-1988007380-A1 | A COMPOSITION FOR THE TOPICAL TREATMENT OF GLAUCOMA OR OCULAR HYPERTENSION | PHARMACIA AB (SE) | 1988-10-06 | — | — | WO | disclosed |